|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘 | Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang | 2010 | The Lancet2010，，9742： | 20 |
| 2 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘 | Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang | 2010 | The Lancet . 2010 (9742)2010，，9742： | 6 |
| 3 | Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study)显示文摘 | Masato Ozaka Yuji Matsumura Hiroshi Ishii Yasushi Omuro Takao Itoi Hisatsugu Mouri Keiji Hanada Yasutoshi Kimura Iruru Maetani Yoshinobu Okabe Masaji Tani Takaaki Ikeda Susumu Hijioka Ryouhei Watanabe Shinya Ohoka Yuki Hirose Masafumi Suyama Naoto Egawa A | 2012 | Cancer Chemotherapy and Pharmacology2012，，5： | 3 |
| 4 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘 | Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang | 2010 | The Lancet2010，，9742： | 2 |
| 5 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘 | Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang | 2010 | 2010 (9742)2010，，9742： | 2 |
| 6 | Therapeutic use of focus night & day contact lenses显示文摘 | Ayfer K Omuro U | 2003 | Cornea2003，22，： | 1 |
| 7 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘 | Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang | 2010 | The Lancet2010，，9742： | 1 |
| 8 | Regression of an unresectable pancreatic tumor following nonmyeloablative allogeneic peripheral-blood stem-cell transplantation 显示文摘 | Omuro Y Matsumoto G Sasaki T | 2003 | Bone Marrow Transplant2003，31，10： | 1 |
| 9 | Vinorelbine com- bined with a protracted course of temozolomide for recurrent brain metastases : a phase I trim 显示文摘 | Omuro AM Raizer JJ Demopoulos A | 2006 | J Neurooncol2006，78，3： | 1 |
| 10 | Delayed neurotox icity in primary central nervous system lymphoma显示文摘 | Omuro AM Ben-Porat LS Panageas KS | | 0，，10： | 1 |
| 11 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘 | Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang | 2010 | The Lancet2010，，9742： | 1 |
| 12 | Glioblastoma and other malignant gliomas: a clinical review显示文摘 | Omuro A DeAngelis LM | 2013 | JAMA2013，310，17： | 1 |
| 13 | SiC devicelimitation breakthrough with novel floating ]unction structure on 4H-SiC 显示文摘 | ADACHI K OMURO I ONO R | 2003 | Materials Science Forum2003，，： | 1 |
| 14 | Amorphization of mechanically alloyed Fe-C and Fe-N materials with additive elements and their concentration dependence显示文摘 | Omuro K Miura H | 1995 | Materials Science Forum1995，，： | 1 |
| 15 | Chemoradio- therapy for primary CNS lymphoma: an intentto-treat analysis with complete follow-up 显示文摘 | Omuro AM DeAngelis LM Yahalom J | 2005 | Neurology2005，64，1： | 1 |
| 16 | Lessons learned in the development of targeted therapy for malignant gliomas显示文摘 | Omuro AM Faivre S Raymond E | 2007 | Mol Cancer Ther2007，6，7： | 1 |
| 17 | Chemotherapy for primary central nervous system lymphoma显示文摘 | Omuro AM Abrey LE | 2006 | Neurosurg Focus2006，21，1： | 1 |
| 18 | Brain metastases 显示文摘 | Omuro AM Abrey LE | 2004 | Neurosci Rep2004，4，3： | 1 |
| 19 | Pitfalls in the diagnosis of brain tumours显示文摘 | Omuro AMP Leite CC Mokhtari K | 2006 | Lancet Neurol2006，5，11： | 1 |
| 20 | Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly显示文摘 | Omuro AM Taillandier L Chinot O | 2007 | J Neurooncol2007，85，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员